Highlights:
- Novel anticoagulants associated with lower all-cause mortality compared to VKAs
- CABANA trial provides important new data on clinical and quality of life effects of ablation for atrial fibrillation
- Profile: Tim Betts
- New guidelines on CV management during pregnancy
